Related Experiment Video
Updated: Nov 2, 2025

The use of Biofeedback in Clinical Virtual Reality: The INTREPID Project
Published on: November 12, 2009
Virtual reality relaxation for the general population: a systematic review
Simon Riches1,2,3, Lisa Azevedo4,5, Leanne Bird6
1Department of Psychology, Institute of Psychiatry, Psychology & Neuroscience, King's College London, De Crespigny Park, London, SE5 8AF, UK. simon.j.riches@kcl.ac.uk.
Virtual reality (VR) using head-mounted displays (HMDs) shows promise for promoting relaxation and reducing stress in the general population. While feasible and acceptable, further rigorous studies are needed to confirm long-term effectiveness.
Area of Science:
- Health Sciences
- Psychology
- Technology Integration
Background:
- Modern lifestyles limit opportunities for relaxation, despite its restorative health benefits.
- Virtual reality (VR) offers immersive experiences in calming virtual environments via head-mounted displays (HMDs).
- VR shows potential as an accessible tool for stress reduction and promoting public health.
Purpose of the Study:
- To systematically review the feasibility, acceptability, and effectiveness of VR interventions for promoting relaxation.
- To evaluate VR's application in enhancing relaxation for the general population.
- To synthesize evidence from studies utilizing HMD technology for relaxation.
Main Methods:
- Systematic literature search of Web of Science, PsycINFO, Embase, and MEDLINE databases up to June 2020.
- Inclusion criteria: studies using HMDs to present virtual environments for relaxation or related variables.
- Methodological quality assessed using the Effective Public Health Practice Project (EPHPP) tool.
Main Results:
- Nineteen studies (1278 participants, 2007-2020) met inclusion criteria; thirteen were controlled.
- Predominant use of natural audio-visual stimuli within VR environments.
- Findings suggest VR is feasible, acceptable, and effective for short-term relaxation and stress reduction.
Conclusions:
- VR presents a viable tool for promoting relaxation, particularly relevant during periods of heightened global stress like the COVID-19 pandemic.
- Current evidence indicates short-term benefits, but methodological limitations exist.
- Further high-quality randomized controlled trials are necessary to establish robust, long-term efficacy of VR for relaxation.
Related Concept Videos
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...

